Citation Impact
Citing Papers
Outcomes in refractory diffuse large B-cell lymphoma: results from the international SCHOLAR-1 study
2017 Standout
Spreading Depression Triggers Headache by Activating Neuronal Panx1 Channels
2013 Science
Results of a Pivotal Phase II Study of Brentuximab Vedotin for Patients With Relapsed or Refractory Hodgkin's Lymphoma
2012 Standout
Pathophysiology of Migraine: A Disorder of Sensory Processing
2017 Standout
Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet
2009 Standout
The ISHAGE Guidelines for CD34+ Cell Determination by Flow Cytometry
1996 Standout
Evaluation of platelet concentrates prepared from buffy coats and stored in a glucose‐free crystalloid medium
1989
5 Treatment and prognostic factors in acute myeloid leukaemia
1996
Etoposide: four decades of development of a topoisomerase II inhibitor
1998 Standout
Disease relapse after haematopoietic stem cell transplantation: Risk factors and treatment
2007
Chimeric Antigen Receptor–Modified T Cells for Acute Lymphoid Leukemia
2013 Standout
Comparison of Platelet‐Rich Plasma Collection Using the Haemonetics PCS and Baxter Autopheresis C
1991
Perspectives on cancer therapy-induced mucosal injury
2004 Standout
Chronic myelogenous leukemia in nonlymphoid blastic phase
1999
Guidelines for Preventing Infectious Complications among Hematopoietic Cell Transplantation Recipients: A Global Perspective
2009 Standout
The role of platelets in blood coagulation—effects of platelet agonists and GPIIb/IIIa inhibitors studied by free oscillation rheometry
2002 StandoutNobel
Regimen-related toxicity and early posttransplant survival in patients undergoing marrow transplantation for lymphoma.
1989 StandoutNobel
High-dose chemoradiotherapy and anti-B-cell monoclonal antibody-purged autologous bone marrow transplantation in mantle-cell lymphoma: no evidence for long-term remission.
1998
Acute graft-vs-host disease
2001
Estimation of failure probabilities in the presence of competing risks: new representations of old estimators
1999 Standout
Normobaric hyperoxia improves cerebral blood flow and oxygenation, and inhibits peri-infarct depolarizations in experimental focal ischaemia
2007
Co‐stimulatory pathways in lymphocyte regulation: the immunoglobulin superfamily
2005 StandoutNobel
The Science of Stroke: Mechanisms in Search of Treatments
2010 Standout
Therapy for cutaneous melanoma: An update
1990
Dose Intensification of Etoposide in the BEAM ABMT Protocol for Malignant Lymphoma
1995
Thrombotic Microangiopathy after Allogeneic Blood and Marrow Transplantation Is Associated with Dose-Intensive Myeloablative Conditioning Regimens, Unrelated Donor, and Methylprednisolone T-Cell Depletion
2004
Factors affecting posttransfusion platelet increments, platelet refractoriness, and platelet transfusion intervals in thrombocytopenic patients
2005
Autologous Bone Marrow Transplantation as Compared with Salvage Chemotherapy in Relapses of Chemotherapy-Sensitive Non-Hodgkin's Lymphoma
1995 Standout
Transplantation-associated thrombotic microangiopathy after steroid pulse therapy for polyserositis related to graft-versus-host disease
2010 StandoutNobel
Multiple myeloma
2000 Standout
Vascular disorders of the liver # †
2008 Standout
Comparison of idarubicin to daunomycin in a randomized multidrug treatment of childhood acute lymphoblastic leukemia at first bone marrow relapse: A report from the Children's Cancer Group
1996
The effect of gamma irradiation on the quality of apheresis platelets during storage for 7 days
2008 StandoutNobel
Chronic graft-versus-host disease
2003 Standout
The Epidemiology of Skin Cancer
1996 Standout
High-ResolutionIn VivoImaging of the Neurovascular Unit during Spreading Depression
2007
Bone marrow transplantation prolongs survival after relapse in aggressive-lymphoma patients treated with the LNH-84 regimen.
1992
High-dose cytarabine and total body irradiation with or without cyclophosphamide as a preparative regimen for marrow transplantation for acute leukemia.
1988
Aptamers as targeted therapeutics: current potential and challenges
2016 Standout
Hematopoietic stem cell compartment: Acute and late effects of radiation therapy and chemotherapy
1995
Glial and neuronal control of brain blood flow
2010 StandoutNature
Graft-versus-host disease
2009 Standout
Two-Photon Imaging during Prolonged Middle Cerebral Artery Occlusion in Mice Reveals Recovery of Dendritic Structure after Reperfusion
2008
Biology and management of relapsed acute myeloid leukaemia
2005
Therapeutic RNA aptamers in clinical trials
2012
Hematopoietic Stem-Cell Transplantation
2006 Standout
Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study
2008 Standout
Stimulus-Induced Changes in Blood Flow and 2-Deoxyglucose Uptake Dissociate in Ipsilateral Somatosensory Cortex
2008
Activity of a Specific Inhibitor of the BCR-ABL Tyrosine Kinase in the Blast Crisis of Chronic Myeloid Leukemia and Acute Lymphoblastic Leukemia with the Philadelphia Chromosome
2001 Standout
Interplay between Cortical Spreading Depolarization and Seizures
2017 Standout
Transplantation of Anergic Histoincompatible Bone Marrow Allografts
1999
Fewer infections and lower infection-related mortality following non-myeloablative versus myeloablative conditioning for allotransplantation of patients with lymphoma
2008
Laser speckle contrast imaging in biomedical optics
2010 Standout
Treatment of advanced acute leukaemia with allogeneic bone marrow transplantation from unrelated donors
1994
Defining the Intensity of Conditioning Regimens: Working Definitions
2009 Standout
Spreading depolarizations cycle around and enlarge focal ischaemic brain lesions
2010
Bone Marrow Transplantation for Treatment of Leukemia in Children
1988
Platelet-Rich Plasma: A Review of Biology and Applications in Plastic Surgery
2006 Standout
A Comparison of Cyclophosphamide and Total Body Irradiation with Etoposide and Total Body Irradiation as Conditioning Regimens for Patients Undergoing Sibling Allografting for Acute Lymphoblastic Leukemia in First or Second Complete Remission
2006
High-dose chemotherapy and autologous hematopoietic stem-cell transplantation for aggressive non-Hodgkin's lymphoma.
1993
Diffuse large B-cell lymphoma
2013
Optogenetics in Neural Systems
2011 Standout
Single-Agent Pixantrone as a Bridge to Autologous Stem Cell Transplantation in a Patient with Refractory Diffuse Large B-Cell Lymphoma
2017 Standout
In Vitro Assessment of the Quality of Stored Platelet Concentrates
1994 Standout
Do minitransplants have minicosts? A cost comparison between myeloablative and nonmyeloablative allogeneic stem cell transplant in patients with acute myeloid leukemia
2005
Intensive Postremission Chemotherapy in Adults with Acute Myeloid Leukemia
1994
Sjögren-Type Syndrome After Allogeneic Bone-Marrow Transplantation
1977
Bone Marrow Transplantation in the Treatment of Children with Cancer: Current Status
1987
Hyperacute graft-v-host disease in patients not given immunosuppression after allogeneic marrow transplantation
1986
Molecular Classification of Cancer: Class Discovery and Class Prediction by Gene Expression Monitoring
1999 StandoutScience
The Role of Cytotoxic Therapy with Hematopoietic Stem Cell Transplantation in the Therapy of Acute Myeloid Leukemia in Children: An Evidence-Based Review
2007
Marrow Transplantation in Thirty "Untransfused" Patients with Severe Aplastic Anemia
1980 StandoutNobel
Propagation of cortical spreading depolarization in the human cortex after malignant stroke
2013
Chemotherapy in 998 unselected childhood acute lymphoblastic leukemia patients. Results and conclusions of the multicenter trial ALL-BFM 86
1994
Acute Myeloid Leukemia
2015 Standout
Acute and chronic graft-versus-host disease in man
1986
Bone Marrow Transplants from HLA-Identical Siblings as Compared with Chemotherapy for Children with Acute Lymphoblastic Leukemia in a Second Remission
1994
Allogeneic hematopoietic stem cell transplantation in children and adolescents with recurrent and refractory Hodgkin lymphoma: an analysis of the European Group for Blood and Marrow Transplantation
2009
FK506 in combination with methotrexate for the prevention of graft- versus-host disease after marrow transplantation from matched unrelated donors
1996
Mouse Model of Microembolic Stroke and Reperfusion
2004
Primary dexamethasone treatment of multiple myeloma
1992
Patients With t(8;21)(q22;q22) and Acute Myeloid Leukemia Have Superior Failure-Free and Overall Survival When Repetitive Cycles of High-Dose Cytarabine Are Administered
1999
Graft-versus-leukemia reactions after bone marrow transplantation
1990 Standout
Comparison of autologous bone marrow transplantation and intensive chemotherapy as postremission therapy in adult acute myeloid leukemia. The Groupe Ouest Est Leucémies Aiguës Myéloblastiques (GOELAM).
1997
Frequency of prolonged remission duration after high-dose cytarabine intensification in acute myeloid leukemia varies by cytogenetic subtype.
1998
Successful engraftment of cryopreserved autologous bone marrow in patients with malignant lymphoma
1978
Graft‐versus‐Host Disease in Dog and Man: The Seattle Experience
1985 StandoutNobel
Veno-Occlusive Disease of the Liver After Allogeneic Bone Marrow Transplantation
1979
Gene correction in hematopoietic progenitor cells by homologous recombination
2000 StandoutNobel
Granulocyte colony-stimulating factor "mobilized" peripheral blood progenitor cells accelerate granulocyte and platelet recovery after high-dose chemotherapy
1993
Allogeneic hematopoietic cell transplantation for adults with acute myeloid leukemia: myths, controversies, and unknowns
2010
The presence of a FLT3 internal tandem duplication in patients with acute myeloid leukemia (AML) adds important prognostic information to cytogenetic risk group and response to the first cycle of chemotherapy: analysis of 854 patients from the United Kingdom Medical Research Council AML 10 and 12 trials
2001 Standout
BONE MARROW TRANSPLANTATION: A REVIEW OF DELAYED COMPLICATIONS
1984 StandoutNobel
Treatment of the Newly Diagnosed Adult with De Noyo Acute Myeloid Leukemia
1993
Marrow transplantation for acute lymphoblastic leukemia: factors affecting relapse and survival
1989
Bone Marrow Transplant
1990 Standout
Treatment of Primary Progressive Hodgkin’s and Aggressive Non-Hodgkin’s Lymphoma: Is There a Chance for Cure?
2000
Platelet Transfusion Therapy
1990
Treatment of non‐Hodgkin's lymphoma with chemoradiotherapy and allogenic marrow transplantation
1983 StandoutNobel
Optogenetic-guided cortical plasticity after nerve injury
2011
High-dose etoposide and cyclophosphamide without bone marrow transplantation for resistant hematologic malignancy
1990
Allogeneic, syngeneic, and autologous marrow transplantation for Hodgkin's disease: the 21-year Seattle experience.
1993
Review of the use of marrow transplantation in the treatment of non-Hodgkin's lymphoma.
1983 StandoutNobel
An analysis of hepatic venocclusive disease and centrilobular hepatic degeneration following bone marrow transplantation
1980 StandoutNobel
Factors affecting thymic function after allogeneic hematopoietic stem cell transplantation
2001
The Importance of Diagnostic Cytogenetics on Outcome in AML: Analysis of 1,612 Patients Entered Into the MRC AML 10 Trial
1998 Standout
World Health Organization Classification of Neoplastic Diseases of the Hematopoietic and Lymphoid Tissues: Report of the Clinical Advisory Committee Meeting—Airlie House, Virginia, November 1997
1999 Standout
Chronic graft-versus-host syndrome in man
1980 Standout
Platelet storage for 7 days in second‐generation blood bags
1986
The World Health Organization (WHO) classification of the myeloid neoplasms
2002 Standout
Risk assessment in haematopoietic stem cell transplantation: Conditioning
2007
Long-term survival of patients with acute myeloid leukemia
1997
Extension of platelet concentrate storage
1983
Works of RH Herzig being referenced
High-dose cytarabine and daunorubicin as consolidation therapy for acute myeloid leukemia in first remission: long-term follow-up and results.
1989
Allogeneic marrow transplantation for refractory Hodgkin's disease.
1989
A detailed analysis of charges for hematopoietic stem cell transplantation at a children’s hospital
1998
The treatment of progressive non-Hodgkin's lymphoma with intensive chemoradiotherapy and autologous marrow transplantation
1990
Incidence of acute graft-versus-host disease with and without methotrexate prophylaxis in allogeneic bone marrow transplant patients
1984
Transfusion experience with platelet concentrates stored for 24 to 72 hours at 22° C
1982
Treatment of progressive Hodgkin's disease with intensive chemoradiotherapy and autologous bone marrow transplantation
1989
High-dose cytosine arabinoside and fractionated total-body irradiation: an improved preparative regimen for bone marrow transplantation of children with acute lymphoblastic leukemia in remission
1988
Automated platelet production during plasmapheresis
1983
High-dose cytosine arabinoside therapy for refractory leukemia
1983
Long-term outcomes of responders in a randomized, controlled phase II trial of aptamer AS1411 in AML.
2010
Correction of poor platelet transfusion responses with leukocyte-poor HL-A-matched platelet concentrates
1975
Treatment of metastatic malignant melanoma with intensive melphalan and autologous bone marrow transplantation.
1985
Bone-marrow transplantation following combination chemotherapy immunosuppression (B.A.C.T.) in patients with acute leukemia.
1974
Bone marrow transplantation for acute leukemia and lymphoma with high-dose cytosine arabinoside and total body irradiation.
1985
Correction of poor platelet transfusion responses with leukocyte-poor HL-A-matched platelet concentrates
1975
High-dose cytarabine for the treatment of blastic phase chronic myelogenous leukemia.
1985
High-dose etoposide, cyclophosphamide, and total body irradiation with allogeneic bone marrow transplantation for patients with acute myeloid leukemia in untreated first relapse: a study by the North American Marrow Transplant Group
1995
High-dose etoposide and cyclophosphamide without bone marrow transplantation for resistant hematologic malignancy
1990